Alpha-2 adrenergic agonist for treating intraocular pressure and ocular diseases through intravitreal and intracameral routes
AssigneeAllergan, Inc.
InventorsMohammed I. DIBAS, Daniel W. GIL, John E. DONELLO
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of lowering intraocular pressure which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin-2-ylamino)benzimidazole, or a salt thereof to the affected eye of a patient, as a single dose, wherein the affected eye has an intraocular pressure less than the baseline.
Claims12
A method of lowering intraocular pressure which comprises administering by direct injection into the eye a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin2-ylamino)benzimidazole or a salt thereof, to the affected eye of a patient, in need thereof, as a single dose.
A method of lowering intraocular pressure of a patient in need thereof which comprises administering by injection into the back of the eye a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin-2-ylamino)benzimidazole or a salt thereof, to the affected eye of said patient, once daily, wherein the affected eye maintains an intraocular pressure less than the baseline intraocular pressure, throughout the day.
A method of lowering intraocular pressure which comprises administering via intracameral route a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin2-ylamino)benzimidazole or a salt thereof, to the affected eye of a patient, in need thereof, as a single dose.
A method of lowering intraocular pressure which comprises administering via intravitreal route a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin2-ylamino)benzimidazole or a salt thereof, to the affected eye of a patient, in need thereof, as a single dose.
Dependencies are inferred from the claim text.